|
|
|
Vol. 14, No. 16, pp. 2097-2105, August 15, 2000
Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hertfordshire EN6 3LD, UK
| |
ABSTRACT |
|---|
|
|
|---|
Escherichia coli alkB mutants are very sensitive to DNA
methylating agents. Despite these mutants being the subject of many studies, no DNA repair or other function has been assigned to the AlkB
protein or to its human homolog. Here, we report that reactivation of
methylmethanesulfonate (MMS)-treated single-stranded DNA phages, M13,
f1, and G4, was decreased dramatically in alkB mutants. No
such decrease occurred when using methylated
phage or M13 duplex
DNA. These data show that alkB mutants have a marked defect
in processing methylation damage in single-stranded DNA. Recombinant
AlkB protein bound more efficiently to single- than double-stranded
DNA. The single-strand damage processed by AlkB was primarily cytotoxic
and not mutagenic and was induced by SN2 methylating agents, MMS, DMS,
and MeI but not by SN1 agent
N-methyl-N-nitrosourea or by
irradiation.
Strains lacking other DNA repair activities, alkA tag, xth nfo, uvrA,
mutS, and umuC, were not defective in reactivation of methylated
M13 phage and did not enhance the defect of an alkB mutant. A
recA mutation caused a small but additive defect. Thus,
AlkB functions in a novel pathway independent of these activities. We
propose that AlkB acts on alkylated single-stranded DNA in replication
forks or at transcribed regions. Consistent with this theory,
stationary phase alkB cells were less MMS sensitive than
rapidly growing cells.
[Key Words: DNA repair; DNA alkylation; AlkB]
| |
Introduction |
|---|
|
|
|---|
Alkylating agents arise endogenously in cells and also occur widely
in the environment (Rebeck and Samson 1991
; Vaughan
et al. 1991
; Taverna and Sedgwick 1996
). As a consequence, cells need
protection against such compounds, which is provided by activities that
specifically remove alkylation lesions from DNA. Inducible resistance
of Escherichia coli to the cytotoxic and mutagenic effects of
simple alkylating agents involves the increased expression of the
ada, alkA, and alkB genes (Lindahl et al.
1988
). The functions of the Ada and AlkA proteins have been studied in
detail, whereas that of AlkB remains unclear. Ada, a multifunctional
protein, directly demethylates O6-methylguanine and
methylphosphotriesters in DNA by transferring methyl groups onto two of
its own cysteine residues. It also positively regulates the adaptive
response using S-diastereoisomers of methylphosphotriesters as
the inducing signal (Lindahl et al. 1988
). AlkA is a
3-methyladenine-DNA glycosylase and excises the toxic lesion
3-methyladenine from DNA. It can also excise other altered bases, such
as hypoxanthine and N6-ethenoadenine (Matijasevic et al.
1992
; Saparbaev and Laval 1994
). The resulting abasic sites are
repaired by the base excision repair pathway (Lindahl et al. 1997
).
O6-methylguanine-DNA methyltransferases and
3-methyladenine-DNA glycosylases are conserved in prokaryotes and
eukaryotes (Pegg et al. 1995
). An additional E. coli function,
AidB, is induced by high concentrations of alkylating agents and is
possibly involved in inactivation of certain alkylating agents (Landini
et al. 1994
).
Conservation of AlkB protein from bacteria to humans indicates its
importance for cellular defence against alkylating agents (Wei et al.
1996
), but its function remains elusive despite its identification in
1983 (Kataoka et al. 1983
). The alkB gene forms a small operon
with ada and is regulated from the ada promoter (Lindahl et al. 1988
). The AlkB protein prevents death from cells' exposure to methylmethanesulfonate (MMS) and dimethylsulphate (DMS) but
is less effective in protection against
N-methyl-N'-nitro-N-nitroguanidine (MNNG) and
N-methyl-N-nitrosourea (MNU; Kataoka et al. 1983
;
Chen et al. 1994
). A small defect in the reactivation of MMS-treated
bacteriophage in an alkB mutant suggests a role for AlkB
in DNA repair (Kataoka et al. 1983
), but the mechanism is unknown. AlkB mutants are not defective in the repair of several
different types of potentially toxic lesions that may be generated by
methylating agents in duplex DNA. These lesions include
3-methyladenine, DNA strand breaks, abasic sites, and secondary lesions
that may arise at abasic sites such as DNA-protein cross-links and
DNA interstrand cross-links (Dinglay et al. 1998
). Purified AlkB
protein is devoid of detectable DNA glycosylase, DNA methyltransferase,
nuclease, or DNA-dependent ATPase activity in standard enzyme assays
(Kondo et al. 1986
) and has no sequence similarity to other proteins of
known function in the databases. Homologs of AlkB have been identified
in Homo sapiens and Caulobacter crescentus (Wei et al. 1996
; Colombi and Gomes 1997
), and recent database searches reveal
a wide distribution of other putative AlkB homolog through evolution
(data not shown). Overexpression of the E. coli AlkB protein
confers MMS resistance to human cells (Chen et al. 1994
), and
conversely, the human protein confers alkylation resistance to E. coli alkB mutants (Wei et al. 1996
), suggesting that AlkB proteins
act independently and not via formation of multiprotein complexes.
Expression of the C. crescentus alkB gene is not induced by
alkylation damage but is cell-cycle regulated with a pattern similar to
activities required for DNA replication (Colombi and Gomes 1997
).
In this article, we describe a substantial defect in the reactivation of MMS-treated single-stranded DNA phages in alkB mutants and show that AlkB protein is required to process toxic DNA damage induced in single-stranded DNA by SN2 methylating agents.
| |
Results |
|---|
|
|
|---|
AlkB processes methylated single-stranded DNA
AlkB mutants are sensitive to killing by MMS but only marginally
sensitive to MNNG. They have a small defect in the reactivation of
MMS-treated
phage, indicating a defect in DNA repair (Kataoka et
al. 1983
). Differences in the known spectra of methylated bases induced
by MMS and MNNG were considered as a possible explanation for the
alkB phenotype. The sites methylated by MMS in duplex DNA are
also modified by MNNG, whereas in single-stranded DNA some sites are
more reactive with MMS than with MNNG (Singer and Grunberger 1983
). To
examine the possibility that the AlkB protein processes damage induced
in single-stranded DNA, reactivation of MMS-treated M13 phage was
monitored in an alkB117::Tn3 mutant. Survival of the
methylated phage was strikingly low in the alkB mutant. The
lethal MMS dose resulting in 10% M13 survival (LD10) was fourfold
lower for the alkB mutant than for the wild type (Fig.
1A). The survival of untreated phage was the same in
both strains. Similar observations were made using two other
single-stranded DNA phages, f1 and G4, when they were treated with MMS
and transfected into alkB117::Tn3 mutants (Fig. 1B,C), whereas
no similar defect was apparent in the reactivation of MMS-treated
, a double-stranded DNA phage (Fig. 1D). The pronounced defect in
reactivation of MMS-treated M13 was also observed in a second
alkB mutant, HK82 (alkB22; data not shown). These
observations indicate that the AlkB protein is required specifically to
process damaged single-stranded DNA or lesions formed more frequently
in single strands but recognized in both single or duplex DNA.
|
Instead of using intact phage, purified M13 DNA in its duplex or single-stranded form was treated with MMS, transformed by heat shock into wild type and alkB117::Tn3 strains and plaque-forming units were monitored. The transformation efficiency of MMS-treated single-stranded DNA was markedly less in the alkB mutant than in the wild type, the LD50 being fivefold less in the alkB mutant (Fig. 2B). In contrast, double-stranded M13 DNA treated with up to 100 mM MMS transformed wild type and alkB strains with equal frequencies and decreased by less than twofold in both strains (Fig. 2A). These observations confirmed that AlkB is required to process methylation lesions in single-stranded DNA.
|
AlkB preferentially binds to single-stranded DNA
To tag the AlkB protein at its amino terminus with six histidines,
the alkB gene was subcloned into a pET15b vector (Studier et
al. 1990
). Expression of the subcloned gene was IPTG
(isopropyl
-D-thiogalactoside) inducible. The new
plasmid construct, pBAR54, complemented MMS sensitivity of an
alkB mutant, demonstrating that the his-tagged AlkB protein
was active in vivo (data not shown). The his-tagged protein was
purified by Ni-NTA-agarose column chromatography (Fig.
3A), and its binding affinities to single-stranded
and duplex DNA in nonmethylated and methylated forms were compared. The
purified protein was incubated with 5'-32P end-labeled
40-mer oligonucleotides, and binding was monitored by nitrocellulose
filter binding assays. AlkB protein bound to both single- and
double-stranded DNA but showed a much greater affinity for
single-stranded DNA. Preferential binding of AlkB to single-stranded
DNA was also confirmed using a gel-shift assay (Ausubel et al. 1999
;
data not shown). Pretreatment of the single- and double-stranded
substrates with a high dose of MMS (300 mM) increased the
AlkB binding affinity by approximately twofold in both cases (Fig. 3B).
However, a similar increase of approximately 2.5-fold was also observed
on pretreatment of the single-stranded DNA with 300 mM MNU
(data not shown). AlkB mutants are not especially sensitive to MNU
(Kataoka et al. 1983
), so the stimulation by high doses of these two
methylating agents may reflect altered structural properties of the
heavily alkylated DNA rather than a binding to a specific lesion
processed by AlkB.
|
AlkB processes DNA damage induced by SN2 methylating agents
SN1 and SN2 alkylating agents react through unimolecular and
bimolecular pathways of nucleophilic substitution, respectively. AlkB
mutants are sensitive to SN2 methylating agents, MMS and DMS, but much
less sensitive to SN1 agents, MNNG and MNU (Kataoka et al. 1983
; Chen
et al. 1994
). To ascertain whether this characteristic also applies to
the survival of single-stranded DNA phage in an alkB mutant,
reactivation of M13 after treatment with DMS, methyl iodide (MeI, also
an SN2 agent), MNU, or
rays was examined in AB1157/F' (wild
type) and BS87/F' (alkB117::Tn3) strains. After exposure
to DMS or MeI, M13 survival was much lower in the alkB mutant
compared with the wild type strain, whereas after treatment with MNU or
rays, survival decreased similarly in both strains (Fig.
4). LD10 of DMS was fivefold lower and LD50 of MeI
sevenfold lower in the alkB mutant. Thus, damage in
single-stranded DNA processed by the AlkB protein is induced
specifically by the SN2 agents MMS, DMS, and MeI but not by MNU or
rays.
|
AlkB function is independent of other DNA repair pathways
AlkA and Tag are 3-methyladenine-DNA glycosylases that repair the
toxic lesion 3-methyladenine. To determine whether these activities
influence survival of damaged single-stranded DNA, M13 phage were
treated with MMS and their survival was assayed in an alkA tag
mutant. This mutant was not defective in reactivating methylated M13
phage, and an alkA tag
(ada-alkB) mutant was no more
deficient than the single alkB mutant (Fig.
5A). In contrast, the alkA tag mutant had a
striking defect in reactivation of MMS-treated
phage, whereas an
alkB mutant showed no defect (Fig. 5B). Reactivation of
MMS-treated M13 phage was also not defective in xth nfo double mutants lacking apurinic endonucleases or in umuC,
uvrA, or mutS mutants defective in error-prone
replication, nucleotide excision repair, or mismatch repair (data not
shown). A recA mutant showed a small reproducible defect in
reactivation of methylated M13 phage, and a recA alkB double
mutant had a slightly greater defect than an alkB single
mutant. The recA and alkB mutant defects were therefore additive, indicating that the two activities work
independently (Fig. 5C).
|
Processing of mutagenic DNA damage by AlkB
The effect of AlkB activity on the spectrum of base substitutions
induced by MMS was examined. Initially, the frequency of lacZ
mutations arising in MMS-treated M13mp18 was analyzed after transfection of F'/wild-type and F'/alkB strains. The
mutation frequencies were low (in the range of
10
4-10
5) but slightly higher in the
alkB mutant than in the wild type (data not shown). With the
aim of increasing the frequency of base substitution mutations, the SOS
response and error-prone replication were induced by direct treatment
of cells with MMS (Schendel and Defais 1980
; Banerjee et al. 1990
). Six
F'lacZ
/
lac strains
(CC101-CC106) that revert to
F'lacZ+/
lac, each by different
targeted base substitution mutations, were used (Cupples and Miller
1989
). Small but reproducible increased frequencies of G:C to A:T, G:C
to T:A, and A:T to T:A base substitutions were observed in
alkB117::Tn3 derivatives of CC102, CC104, and CC105,
respectively, compared with the relevant wild-type strains (Fig.
6). Other types of base substitutions in
alkB derivatives of CC101, CC103, and CC106 were not detected
(data not shown). Ada ogt mutants are sensitive to induction
of GC to AT transition mutations by DNA methylating agents (Mackay et
al. 1994
). The alkB mutants were only weakly sensitive to MMS
mutagenesis compared with CC102
(ada-alkB) ogt (Fig. 6).
|
AlkB mutants in stationary phase are less sensitive to MMS
Stationary phase cells have fewer DNA replication forks (Kornberg
and Baker 1992
) and are less active in transcription than rapidly
growing cells and may, therefore, contain fewer regions of
single-stranded DNA. Consequently, alkB cells deficient in processing damaged single-stranded DNA may be less sensitive to MMS in
stationary phase than during exponential growth. As expected, exponentially proliferating alkB cells were much more
sensitive to MMS than wild-type cells growing at a similar rate. The
MMS sensitivity of alkB cells was significantly reduced when
in stationary phase, whereas wild type stationary and exponential cells
had only a small difference in sensitivity (Fig. 7A).
This latter observation indicated that uptake or reactivity of MMS was
not dramatically reduced in stationary phase and so was not the reason for decreased sensitivity of the stationary alkB cells. A
difference between exponential and stationary alkB cells was
not observed in the reactivation of MMS-treated M13 phage in agreement
with the concept that the reduced sensitivity of alkB
stationary cells to direct MMS treatment is due to a low content of
single-stranded DNA sequences (Fig. 7B).
|
| |
Discussion |
|---|
|
|
|---|
Homologs of the alkB gene have been identified in several
bacterial genomes, Schizosaccharomyces pombe, Drosophila
melanogaster, Arabidopsis thaliana, and Homo
sapiens, but not in Saccharomyces cerevisiae (data not
shown; Wei et al. 1996
; Colombi and Gomes 1997
). Persistence of the
AlkB protein through evolution indicates an important functional role
in cellular responses to alkylating agents that make up the largest
group of environmental genotoxic compounds. No significant homology of
AlkB to other known DNA-processing activities has been found by
database searches, although a novel hydrolase domain has been suggested
(Aravind et al. 1999
). Early observations indicated a possible minor
role for AlkB in processing damage in methylated duplex DNA (Kataoka et
al. 1983
). Here, by phage reactivation experiments and cellular
transformation with isolated DNA, we observed an extreme deficiency in
the ability of alkB mutants to process methylated
single-stranded DNA but little if any defect in processing
double-stranded DNA. These observations provide conclusive evidence
that AlkB protein processes DNA damage and deals with lesions produced
in single-stranded DNA. In addition, we have shown that AlkB binds
preferentially to single-stranded DNA. These findings provide crucial
steps forward in elucidating the function of the AlkB protein.
The E. coli Tag and AlkA 3-methyladenine-DNA glycosylases
excise toxic 3-methyladenine residues from duplex DNA. AlkA protein in
vitro can also act on single-stranded DNA but with a low efficiency (Bjelland and Seeberg 1996
). By phage reactivation experiments, we
found that an alkA tag strain was not defective in processing methylated single-stranded DNA in vivo. This observation suggests that
AlkA is either not active on DNA single strands in vivo or that the
apurinic sites resulting from its activity on single-stranded DNA have
a similar toxicity to 3-methyladenine. The alkA tag
(ada-alkB) mutant was no more defective in processing
single-stranded DNA than the alkB single mutant. Processing of
methylated lesions in DNA single strands by AlkB therefore does not
involve cooperation with 3-methyladenine-DNA glycosylases. Additive
sensitivity of an alkA alkB double mutant to MMS has been
noted previously (Volkert and Hajec 1991
).
The alkB mutants investigated were only weakly susceptible to MMS-induced base substitution mutagenesis. Thus, the lesions processed by AlkB in DNA single strands have a low capacity for mispairing during DNA replication. Also, processing of DNA damage by AlkB protein in wild-type strains reduced mutagenesis rather than causing it and, so, is unlikely to involve inaccurate replication past blocking lesions. In addition to this, survival of MMS-treated M13 phage was not reduced in a umuC mutant, indicating that AlkB protein does not cooperate with UmuC to allow replication past the damage. Considering the possibility that AlkB may be involved in accurate lesion bypass, it is of note that the survival of MMS-treated M13 phage was not reduced in xth nfo or uvrA mutants. Base excision or nucleotide excision repair therefore do not excise the damage from double-stranded DNA after lesion bypass events. A recA mutant had a small defect in processing methylated single-stranded DNA. Our evidence indicated that AlkB and RecA proteins act in different processes and, therefore, RecA may provide a minor alternative pathway for dealing with the damage in single-stranded DNA.
A unique characteristic of alkB mutants is their extreme
sensitivity to SN2 but not SN1 methylating agents (Kataoka et al. 1983
). Here, the cytotoxic lesions processed by AlkB in single-stranded DNA were similarly induced by several SN2 methylating agents, DMS, MMS,
and MeI, but not by the SN1 agent MNU or by
irradiation. Both SN1
and SN2 methylating agents induce N7-methylguanine and
N3-methyladenine in single-stranded DNA (Singer and
Grunberger 1983
). Modification at these sites destabilizes the glycosyl
bond, and any base loss results in toxic apurinic sites. Since MNU does not induce the lesions that are processed by AlkB protein but does
induce N7-methylguanine, N3-methyladenine, and
apurinic sites, these lesions were excluded as substrates of AlkB.
The observation that AlkB protein processes damaged single-stranded DNA
also eliminates DNA interstrand cross-links as its substrate. Our
attention was drawn to sites that are normally protected from
methylation by hydrogen bonding in duplex DNA but that are more
reactive in single-stranded DNA. Thus, N1-methyladenine and
N3-methylcytosine are induced by MMS more readily in single
than double strands, and this effect is less pronounced for MNU (Singer and Grunberger 1983
). N3-methylcytosine residues block DNA
replication in vitro, and this may also be the case for
N1-methyladenine because of disruption of base pairing and
inability to form stable base pairs (Abbott and Saffhill 1977
; Boiteux
and Laval 1982
; Saffhill 1984
; Larson et al. 1985
). Because of their potential cytotoxicity, we propose these lesions as candidate substrates for the AlkB protein. However, active removal of
radiolabeled N1-methyladenine or N3-methylcytosine
promoted by AlkB from cellular DNA in vivo or from DNA substrates by
purified AlkB protein has not been detected (data not shown). Also, the
spectrum of base substitution mutations in an MMS-treated alkB
mutant did not point to a particular modified base as the substrate of
AlkB. The mutation frequencies for three out of six possible
substitutions showed a small increase, but the mutations occurred in
both GC and AT base pairs.
The specificity of AlkB protein in processing damage in DNA single strands suggests that AlkB acts at DNA replication forks or at sites of transcription. This model is supported by the observation that rapidly growing AlkB cells are more sensitive to MMS than those in stationary phase, whereas the growth stage of the cells did not affect survival of MMS-treated M13 phage. Lesions that arise in the replication fork and block DNA synthesis will require rapid repair or bypass replication. We propose that AlkB is involved in either of these processes functioning in an apparently accurate manner and playing a similar critical role in the cellular defence against methylating agents both in E. coli and mammalian cells.
| |
Materials and methods |
|---|
|
|
|---|
Materials
MMS, DMS, and MeI were purchased from Aldrich; M13mp18 RF1 DNA from Pharmacia Biotech; and MNU was a kind gift from P. Swann, University College London.
Bacterial strains
E. coli strains are listed in Table 1.
New E. coli K12 strains were constructed by transduction using
P1 cml clr 100 bacteriophage (Sedgwick 1982
). The
alkB117::Tn3,
(ada-alkB25::Camr), and
(srlR-recA)306::Tn10 transductants were selected on LB agar
containing 50 µg/ml carbenicillin, 20 µg/ml chloramphenicol, or
15 µg/ml tetracyline, respectively. Enhanced MMS sensitivity of
alkB transductants compared with the parent strains was
verified by streaking 10 µl of cultures (A450 0.4) across
a gradient of 0-11.8 mM MMS in a 10-cm square
Luria-Bertani (LB) agar plate and incubating at 37°C.
F'proAB+ lacIQ lacZ
M15
Tn10 was transferred from XL1-Blue (Stratagene) into several strains
and selected by plating on LB agar containing 15 µg/ml tetracycline
and 200 µg/ml streptomycin for counterselection. Most F'
strains used in M13 and f1 phage survival and mutagenesis experiments
contained this F' factor. The exceptions were
(srlR-recA)306::Tn10 strains that carried
F'proAB+ lacIQ lacZ
M15 Tn5
(Stratagene) selected on 40 µg/ml kanamycin. F'148 (his+-aroD+) was transferred from KLF48/KL159 (Coli
Genetic Stock Center) into BS87 (alkB117::Tn3) and selected by
plating on M9 minimal agar supplemented with 20 µg/ml required
amino acids except histidine and 50 µg/ml carbenicillin.
F'148/BS87 was then used to transfer the alkB117::Tn3
mutation into E. coli C-1 by F'-mediated transfer (Miller
1972
), and BS159 (E. coli C-1 alkB117::Tn3) was selected on M9
minimal agar containing carbenicillin without amino acid supplements.
|
Preparation and titration of bacteriophage lysates
Bacteria were grown in LB broth. Tetracycline was added for strains
carrying the F' proAB+ lacIQ
lacZ
M15 Tn10 factor. M13mp18 and f1 phage lysates of strain AB1157/F' and
gv lysates of AB1157 were prepared as
described (Sambrook et al. 1989
; Dinglay et al. 1998
). G4 phage lysates were prepared using E. coli C-1. G4 phage
(2 × 104 pfu) and 5 mM CaCl2 were
added to 1 ml E. coli C-1 culture (A600 0.25) and
incubated without shaking at 37°C for 10 min. Thirty ml LB broth
containing 5 mM CaCl2 were then added and
incubated for 6 hr. After adding 100 µl chloroform, the lysate was
centrifuged at 7600g for 10 min, and the supernatant retained.
To titer, M13, f1, and G4 phage were serially diluted and 100-µl
aliquots were plated with 100 µl of late exponential cultures of
host bacteria (A600 0.8) in 3 ml melted soft LB agar on LB
agar plates and incubated overnight at 37°C. Phage survival was
monitored by plaque formation. Phage
were titered as described
previously (Dinglay et al. 1998
).
Survival of bacteriophage after treatment with DNA-damaging agents
MNU was dissolved in 10 mM potassium acetate (pH 4.5)
and aliquots stored at
20°C. Phage lysates were diluted to
8 × 109 pfu/ml in M9 minimal salts and 10 mM
MgSO4 and mixed with an equal volume of methylating agent
(MMS, DMS, MeI, or MNU) freshly diluted to various concentrations in
the same medium. After incubation at 30°C for 30 min (unless
otherwise indicated), the phage suspensions were diluted immediately in
M9 salts and 1 mM MgSO4 and titered for survival.
M13 phage (4 × 108 pfu/ml) exposed for various times to
irradiation emitted by a CSL 15-137 Cs source at 2.71 Gy/min
were similarly titered for survival.
Transformation with MMS-treated M13 single-stranded or double-stranded DNA
Isolation of M13mp18 single-stranded DNA, preparation of competent
cells by treatment with CaCl2, and transformation of these cells with M13 DNA were as described (Sambrook et al. 1989
). To assay
for pfu, AB1157 or BS87 (alkB117::Tn3) cells transformed with
M13 DNA were plated in LB soft agar together with AB1157/F' or
BS87/F', respectively. The frequency of transformation was assayed
over several concentrations of single-stranded or double-stranded M13
DNA in order to define the linear range. In this range, 20 ng
double-stranded DNA gave approximately 6000 transfectants and 100 ng
single-stranded DNA gave approximately 2000 transfectants. When
treating with MMS, 1 µl DNA (100 ng double stranded or 500 ng
single stranded) was incubated with 1 µl MMS at various
concentrations in M9 minimal salts and 10 mM
MgSO4 at 30°C for 30 min. The MMS was diluted immediately
by adding 18 µl 10 mM Tris-HCl and 1 mM EDTA (pH 8). Four microliters of the treated DNA was added to 50 µl
competent cells to monitor the transformation frequency.
Sensitivity of alkB mutants to MMS mutagenesis
Strains CC101-CC106 (Miller 1992
) and their alkB117::Tn3
derivatives were grown in M9 minimal salts media to A450 0.5. Aliquots were treated with various concentrations of MMS at 37°C for
20 min, washed in M9 salts containing 1 mM MgSO4,
and then serially diluted in the same buffer. Cells were plated on LB
agar to estimate survival and on minimal media plates containing 0.2%
lactose to monitor Lac+ mutant colonies. The plates were
incubated at 37°C.
Sensitivity of exponential and stationary phase cells to MMS
Cells were cultured in M9 minimal media supplemented with 0.2%
casein amino acid hydrolysate (Sigma-Aldrich) and thiamine hydrochloride (Miller 1992
). Cultures were exposed to MMS either during
exponential growth at A450 0.5 or 16 hr after entering stationary phase at A450 1.3. The MMS treatments were at
37°C for 20 min, and the cells were immediately diluted and plated on LB agar plates to monitor cell survival.
Subcloning of the alkB gene and purification of his-tagged AlkB protein
Oligonucleotide primers were synthesized on an Applied Biosystems
394 DNA Synthesizer. The alkB gene in plasmid pCS70 (Teo et
al. 1984
) was amplified by PCR, using Pfu polymerase (Stratagene) and
two primers 5'-GGAGAGCATATGTTGGATCTGTTTGCCGAT-3' and
5'-ATTCGGATCCTTATTCTTTTTTACCTGCCT-3', to engineer
NdeI and BamHI restriction sites at the 5' and
3' ends of the gene, respectively. The PCR product was digested
with NdeI and BamHI and inserted into the vector
pET15b (Novagen). The DNA sequence of the insert was verified to be
correct by sequencing both DNA strands. The new construct, pBAR54,
encoded the AlkB protein with a tag of six histidines attached to its
amino terminus. This plasmid was transformed into BL21.DE3, in which
expression of the cloned gene was induced by IPTG (Studier et al.
1990
). SDS-PAGE and Western blotting using anti-AlkB polyclonal
antibodies monitored induction of the AlkB protein.
BL21.DE3/pBAR54 was cultured in 270 ml LB broth and 50 µg/ml
carbenicillin to A600 0.5 at 37°C. IPTG 1 mM
was added and the incubation continued for 3 hr. The cells were
harvested, washed in PBSA, and resuspended in 8.5 ml 50 mM
Hepes-KOH (pH 8) 2 mM
-mercaptoethanol, 5% glycerol,
and 300 mM NaCl. After sonication, the extract was
clarified by centrifugation. The extract (55 mg total protein) was
supplemented with 1 mM imidazole and loaded onto a 1-ml
Ni-NTA (nitrilotriacetic acid)-agarose column (Qiagen) previously
equilibrated in buffer (50 mM Hepes-KOH at pH 8, 2 mM
-mercaptoethanol, 5% glycerol, 100 mM
NaCl, 1 mM imidazole). The column was washed with 20 ml
buffer and then 30 ml buffer containing 40 mM imidazole
followed by 5 ml buffer containing 60 mM imidazole. The
AlkB protein was eluted in buffer containing 250 mM
imidazole. A280 readings and visualization by
SDS-polyacrylamide gel electrophoresis located the fractions
containing pure AlkB protein. The purified his-tagged AlkB protein (1.9 mg) was dialysed into 30 mM potassium phosphate (pH 7.5), 2 mM DTT, 3 mM EDTA, 300 mM NaCl, and
50% glycerol and stored at
80°C.
Binding of his-tagged AlkB protein to DNA
A 40-mer oligonucleotide,
5'-AACGCTACTACTATTAGTAGAATTGATGCCACCTTTTCAG-3', was 5'
phosphorylated using [
-32P]ATP and T4 polynucleotide
kinase (New England Biolabs). To prepare double-stranded DNA, the
end-labeled oligonucleotide was annealed to a twofold excess of
complementary strand by heating at 95°C for 2 min and cooling slowly
to room temperature (~4 hr). Single- and double-stranded
oligonucleotides were treated with 300 mM MMS at 30°C
for 30 min and the MMS removed by centrifugation through a Sephadex G50
column equilibrated in 10 mM Tris-HCl and 1 mM EDTA (pH 8). Varying amounts of his-tagged AlkB protein were incubated with [32P]-5' end-labeled DNA oligomers (30,000 cpm/reaction) in 20 µl buffer (20 mM Tris-HCl at pH
7.5, 100 mM KCl, 0.1 mM DTT, 10% glycerol) at
30°C for 30 min. After addition of 1 ml ice-cold buffer, the
reaction mixture was immediately filtered through nitrocellulose disc
filters (HAW P02500 Scheibenfilter, Millipore) using a vacuum
filtration apparatus (Millipore). The filters were washed with 10 ml of
buffer and dried. Scintillation counting quantitated labeled DNA bound
to AlkB protein.
| |
Acknowledgments |
|---|
We thank Lauren Posnick, Peter Karran, and Richard Wood for discussions and John Sguoros and Michael Mitchell for help with homology searches. This work was supported by the Imperial Cancer Research Fund.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
Received March 27, 2000; revised version accepted June 15, 2000.
1 Corresponding author.
E-MAIL b.sedgwick{at}icrf.icnet.uk; FAX 171-269-3801
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Ringvoll, M. N. Moen, L. M. Nordstrand, L. B. Meira, B. Pang, A. Bekkelund, P. C. Dedon, S. Bjelland, L. D. Samson, P. O. Falnes, et al. AlkB Homologue 2-Mediated Repair of Ethenoadenine Lesions in Mammalian DNA Cancer Res., June 1, 2008; 68(11): 4142 - 4149. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Valenti, A. Napoli, M. C. Ferrara, M. Nadal, M. Rossi, and M. Ciaramella Selective degradation of reverse gyrase and DNA fragmentation induced by alkylating agent in the archaeon Sulfolobus solfataricus. Nucleic Acids Res., January 1, 2006; 34(7): 2098 - 2108. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Lee, S.-G. Jin, S. Cai, Y. Chen, G. P. Pfeifer, and T. R. O'Connor Repair of Methylation Damage in DNA and RNA by Mammalian AlkB Homologues J. Biol. Chem., November 25, 2005; 280(47): 39448 - 39459. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Konishi, M. Nakamura, E. Ishida, K. Shimada, E. Mitsui, R. Yoshikawa, H. Yamamoto, and K. Tsujikawa High Expression of a New Marker PCA-1 in Human Prostate Carcinoma Clin. Cancer Res., July 15, 2005; 11(14): 5090 - 5097. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Delaney and J. M. Essigmann Mutagenesis, genotoxicity, and repair of 1-methyladenine, 3-alkylcytosines, 1-methylguanine, and 3-methylthymine in alkB Escherichia coli PNAS, September 28, 2004; 101(39): 14051 - 14056. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Koivisto, P. Robins, T. Lindahl, and B. Sedgwick Demethylation of 3-Methylthymine in DNA by Bacterial and Human DNA Dioxygenases J. Biol. Chem., September 24, 2004; 279(39): 40470 - 40474. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mishina, C.-H. J. Lee, and C. He Interaction of human and bacterial AlkB proteins with DNA as probed through chemical cross-linking studies Nucleic Acids Res., March 5, 2004; 32(4): 1548 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Koivisto, T. Duncan, T. Lindahl, and B. Sedgwick Minimal Methylated Substrate and Extended Substrate Range of Escherichia coli AlkB Protein, a 1-Methyladenine-DNA Dioxygenase J. Biol. Chem., November 7, 2003; 278(45): 44348 - 44354. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. D. Welford, I. Schlemminger, L. A. McNeill, K. S. Hewitson, and C. J. Schofield The Selectivity and Inhibition of AlkB J. Biol. Chem., March 14, 2003; 278(12): 10157 - 10161. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Duncan, S. C. Trewick, P. Koivisto, P. A. Bates, T. Lindahl, and B. Sedgwick Reversal of DNA alkylation damage by two human dioxygenases PNAS, December 24, 2002; 99(26): 16660 - 16665. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Landini and M. R. Volkert Regulatory Responses of the Adaptive Response to Alkylation Damage: a Simple Regulon with Complex Regulatory Features J. Bacteriol., December 1, 2000; 182(23): 6543 - 6549. [Full Text] |
||||